stoxline Quote Chart Rank Option Currency Glossary
  
BioPlus Acquisition Corp. (BIOS)
10.795  -0.005 (-0.05%)    10-06 15:46
Open: 10.795
High: 10.8
Volume: 5,636
  
Pre. Close: 10.8
Low: 10.7902
Market Cap: 209(M)
Technical analysis
Short term     
Mid term     
Targets 6-month :  1-year : 
Resists First :  Second : 
Pivot price
Supports First :  Second : 
MAs MA(5) :  MA(20) : 
MA(100) :  MA(250) : 
MACD MACD :  Signal : 
%K %D K(14,3) :  D(3) : 
RSI RSI(14):
52-week High :  Low : 
Price, MAs and Bollinger Bands


Stock Price Prediction
If tomorrow: Open lower Open higher
High: - -
Low: - -
Close: - -
Company Description

Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.

Headline News

Wed, 02 Sep 2026
BioPlus Acquisition Corp (BIOS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Sun, 30 Aug 2026
BioPlus Acquisition Corp (BIOS) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

Wed, 16 Aug 2023
Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring - GlobeNewswire

Thu, 04 May 2023
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation - Diagnostic and Interventional Cardiology

Sat, 10 Dec 2022
Alex Serge Vieux Net Worth (2026) - GuruFocus

Wed, 14 Oct 2026

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Financial Services
Industry:
Shell Companies
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders (%)
Held by Institutions (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS
EPS Est Next Qtrly
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin %
Operating Margin %
Return on Assets (ttm) %
Return on Equity (ttm) %
Qtrly Rev. Growth %
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow
Stock Dividends
Dividend
Forward Dividend
Dividend Yield 0%
Dividend Pay Date
Ex-Dividend Date

StockChart iOS

Stoxline iOS

Alpha Bridge iOS

OptionCalc iOS

StockChart Android

Stoxline Android

Alpha Bridge Android

OptionCalc Android